Xilio Development Inc (XLO)

Currency in USD
8.510
-0.050(-0.58%)
Closed·
8.5100.000(0.00%)
·
XLO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8.4658.810
52 wk Range
6.46516.520
Key Statistics
Prev. Close
8.56
Open
8.52
Day's Range
8.465-8.81
52 wk Range
6.465-16.52
Volume
12.65K
Average Volume (3m)
38.62K
1-Year Change
-14.2656%
Book Value / Share
-2.19
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
XLO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
20.000
Upside
+135.02%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Xilio Development Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company’s checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.

Compare XLO to Peers and Sector

Metrics to compare
XLO
Peers
Sector
Relationship
P/E Ratio
−0.7x−8.1x−0.4x
PEG Ratio
−0.030.010.00
Price/Book
−4.8x2.2x2.6x
Price / LTM Sales
1.2x8.6x3.2x
Upside (Analyst Target)
264.1%52.6%50.9%
Fair Value Upside
Unlock5.5%6.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 20.000
(+135.02% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Leerink Partners
Buy2.00-76.50%-New Coverage06/08/2025

Earnings

Latest Release
16/03/2026
EPS / Forecast
0.81 / -0.07
Revenue / Forecast
13.69M / 10.9M
EPS Revisions
Last 90 days

People Also Watch

15.28
NN
+1.13%
13.47
ACNT
+1.58%
16.540
UGRO
+6.85%
1.550
MCHX
-1.27%
2.590
DWSN
-7.83%

FAQ

What Is the Xilio Development (XLO) Share Price Today?

The Xilio Development stock price today is 8.510 USD.

What Stock Exchange Does Xilio Development (XLO) Trade On?

Xilio Development is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Xilio Development?

The stock symbol (also called a 'ticker') for Xilio Development is "XLO."

What Is the Current Xilio Development Market Cap?

As of today, Xilio Development market cap is 49.210M USD.

What Is Xilio Development's (XLO) Earnings Per Share (TTM)?

The Xilio Development EPS is currently -7.733 (Trailing Twelve Months).

When Is the Next Xilio Development Earnings Date?

Xilio Development's next earnings report will be released on 07/05/2026.

Is XLO a Buy or Sell From a Technical Analyst Perspective?

Based on today's Xilio Development moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Xilio Development Stock Split?

Xilio Development has split 1 times. (See the XLO stock split history page for full effective split date and price information.)

How Many Employees Does Xilio Development Have?

Xilio Development has 76 employees.

What is the current trading status of Xilio Development (XLO)?

As of 11/04/2026, Xilio Development (XLO) is trading at a price of 8.510 USD, with a previous close of 8.560 USD. The stock has fluctuated within a day range of 8.465 USD to 8.810 USD, while its 52-week range spans from 6.465 USD to 16.520 USD.

What Is Xilio Development (XLO) Price Target According to Analysts?

The average 12-month price target for Xilio Development is 20.000 USD, with a high estimate of 20 USD and a low estimate of 20 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +135.02% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.